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Abstract
Preferential neuronal vulnerability is characteristic of several neurodegenerative diseases including the motor neuron disease
amyotrophic lateral sclerosis (ALS). It is well established that glia play a critical role in ALS, but it is unknown whether regional
differences in the ability of glia to support motor neurons contribute to the specific pattern of neuronal degeneration. In this study,
using primary mixed glial cultures from different mouse CNS regions (spinal cord and cortex), we examined whether regional
differences exist in key glial pathways that contribute to, or protect against, motor neuron degeneration. Specifically, we
examined the NF-κB-mediated inflammatory pathway and the cytoprotective heat shock response (HSR). Glial cultures were
treated with pro-inflammatory stimuli, tumour necrosis factor-ɑ/lipopolysaccharide or heat stressed to stimulate the inflammatory
and HSR respectively. We found that spinal cord glia expressed more iNOS and produced more NO compared to cortical glia in
response to inflammatory stimuli. Intriguingly, we found that expression of ALS-causing SOD1G93A did not elevate the levels of
NO in spinal cord glia. However, activation of the stress-responsive HSR was attenuated in SOD1G93A cultures, with a reduced
Hsp70 induction in response to stressful stimuli. Exposure of spinal cord glia to heat shock in combination with inflammatory
stimuli reduced the activation of the inflammatory response. The results of this study suggest that impaired heat shock response in
SOD1G93A glia may contribute to the exacerbated inflammatory reactions observed in ALS mice.
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Introduction
The majority of cells in the CNS are glial cells, including
astroglia and oligodendrocytes as well as microglia, which
are derived from haematopoietic cells that infiltrate the CNS
during development and act as the resident macrophages of
the CNS. Together, glial cells play crucial roles in the mainte-
nance of normal neuronal function, providing metabolic sup-
port and regulating synaptic networks, while also conferring
protection under conditions of cellular stress (Khakh and
Sofroniew 2015; Marina et al. 2018).
Unsurprisingly, for a cellular component so abundant in the
CNS, in neurodegenerative conditions such as amyotrophic
lateral sclerosis (ALS), glial cells are now known to play a
critical role in the progression of disease. Glia actively con-
tribute towards motor neuron death in ALS by propagating a
toxic pro-inflammatory environment for motor neurons (Chen
et al. 2018; Haidet-Phillips et al. 2011). In mutant SOD1
mouse models of ALS that recapitulate several aspects of the
disease including neuroinflammation, motor neuron loss and
reduced lifespan, deletion of the mutant gene from either
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astroglia or microglia slows the progression of disease
(Boillee et al. 2006; Yamanaka et al. 2008). Furthermore, mu-
tant SOD1–expressing astroglia and microglia are toxic to
motor neurons in co-culture (Bilsland et al. 2008; Frakes
et al. 2014; Nagai et al. 2007). Although the precise mecha-
nisms of this non-cell autonomous motor neuron death remain
unknown, the release of an unidentified toxic factor (Re et al.
2014), loss of trophic support mechanisms (Ferraiuolo et al.
2011; Rothstein et al. 1995), dysregulation of stress-inducible
responses and/or dysregulation of the immune response
(Puentes et al. 2016) have all been reported to be involved.
Glia exist as regional subtypes based on differential
transcriptomes and proteomes (Barbin et al. 1988; Zhang
and Barres 2010; Molofsky et al. 2014; Hochstim et al.
2008; Grabert et al. 2016). The development of glial sub-
types is dependent on distinct molecular signatures (Chai
et al. 2017; Ben Haim and Rowitch 2017; de Haas et al.
2008). Not only do spinal cord and cortical glial cultures
differ in their abundance of astroglial and microglial sub-
types, they also display marked functional differences
(Barbin et al. 1988; Grabert et al. 2016; Schitine et al.
2015). For example, cortical glia promote neuronal den-
drite development far more than spinal cord glia (Leroux
and Reh 1994) and the glutamate transporter GLT-1 is
expressed 10-fold higher in cortical astroglia than in spi-
nal cord astroglia (Regan et al. 2007). Furthermore, dif-
ferences between cortical and spinal cord glia in potassi-
um buffering results in marked differences in synaptic
regulation (Oberheim et al. 2012). As neurodegenerative
diseases are characterised by the loss of specific neuronal
populations, surrounding glial populations may display
functional differences in vulnerable regions of the CNS,
contributing to disease in a region-specific manner. It is
possible that regional differences in glia play a role in the
selective degeneration of motor neurons in the SOD1G93A
mouse model of ALS, in which motor neuron death oc-
curs earlier and to the greatest extent in the spinal cord
(Leichsenring et al. 2006).
One of the major roles of glial cells in the CNS is to act as
part of the immune system. Although microglia are the resi-
dent immune cells of the CNS, astroglia also play a role in
both mediating and responding to microglial activation in re-
sponse to cell damage and infection (Liddelow and Barres
2017; Liddelow et al. 2017; Ouali Alami et al. 2018).
Chronic neuroinflammation is a major pathological hallmark
of ALS and is driven by the pro-inflammatory activities of
microglia and astroglia in the CNS (Philips and Robberecht
2011; Hooten et al. 2015). Activation of microglia and
astroglia in response to inflammatory stimuli such as acute
traumatic injury and neurodegenerative conditions can lead
to the activation of irreversible self–destructing pathways, me-
diated by the inflammatory transcription factor NF-κB
(Akama and Van Eldik 2000; Birck et al. 2016). This process
involves the activation of inflammatory mediators such as
inducible nitric oxide synthase (iNOS), producing highly ox-
idative nitric oxide (NO). Excessive NO production in the
CNS contributes to neuronal damage leading to neuronal loss
in ALS and other neurodegenerative conditions (Yuste et al.
2015; Drechsel et al. 2012).
Glial cells also confer protection to neurons through the
protective intracellular heat shock response (HSR) (Gleixner
et al. 2016; Xia et al. 2016). The HSR is activated under
conditions of cellular stress and leads to an increase in the
synthesis of several stress-inducible chaperones called heat
shock proteins (Hsps) in the cytosol and in subcellular organ-
elles such as the ER and mitochondria (Kalmar and
Greensmith 2017). The main effector of the HSR is the cyto-
solic Hsp70, which is highly inducible in some neuronal pop-
ulations as well as glial cells under a wide range of stressful
stimuli (Manzerra and Brown 1996; Magrane et al. 2004).
Hsp70 has been shown to be protective to glia and indirectly
to neurons (Xu et al. 2010). Interestingly, spinal cord motor
neurons have a surprisingly high threshold for the induction of
the HSR, possibly due to a reliance on the supply of Hsps from
glia (Guzhova et al. 2001; Batulan et al. 2003; Robinson et al.
2005). Under normal physiological conditions, the inflamma-
tory and HSR pathways counterbalance each other, with
Hsp70 acting as an inhibitor of the NF-κB inflammatory path-
way (Kim et al. 2015; Kacimi and Yenari 2015; Feinstein et al.
1996).
In this study, we compared the stress responses of primary
cortical and spinal cord mixed glial cultures obtained from
neonatal mice in response to exposure to heat shock and in-
flammatory stimuli. This model enables the study of the com-
plex interactions between different glial populations, provid-
ing a closer in vitro representation of the cortex or spinal cord
than pure astroglial or microglial cultures. Hsp70 expression
levels were used as a marker of activation of the HSR and
measurements of NO release and iNOS expression were used
to assess activation of the NF-κB-mediated inflammatory
pathway. Finally, we explored whether regional differences
between cortical and spinal cord glia are altered in cultures
obtained from mice expressing mutant SOD1G93A, a model of
mutant SOD1–induced ALS in which inflammatory and neu-
ronal damage occurs to a greater extent in the spinal cord than
in the cortex. The results of our study provide evidence for the
regional specificity of glial stress responses and suggest that
impairments in the HSR of SOD1G93A glia might contribute to
the excessive neuroinflammation that is known to play a role
in motor neuron degeneration in ALS.
Results
The stress-induced responses of glia from different regions of
the CNS were examined in vitro in mixed glial cultures
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established from the spinal cord and cortex firstly of neonatal
wild-type (WT) mice and, subsequently, in glia derived from
SOD1G93A mice that model ALS. In this study, we examined
two key stress responses of glial cells: the response to (i)
inflammatory mediators and (ii) the HSR. To ensure that our
assessments reflected true regional differences in glial func-
tion and were not the result of different cellular composition of
cultures from different CNS regions, we first established the
cellular composition of the mixed glial cultures derived from
the cortex and spinal cord of wild-type mice. The analysis of
the composition of cortical- and spinal cord–derived mixed
glial cultures included immunofluorescence, ELISA and
FACS analysis using GFAP as an astroglial marker and Iba1
or CD11b as a microglial marker (Fig. 1).
Mixed glial cultures from the cortex and spinal cord
consist of similar proportions of astroglia
and microglia
Analysis of immunofluorescence staining for cell-specific
markers demonstrated comparable proportions of GFAP-
positive cells and Iba-1-positive cells in cortical and spinal
cord cultures (Fig. 1a, b). The total GFAP content in whole
cell lysates of both cultures determined by ELISA supported
the immunofluorescence findings and showed no difference in
GFAP levels between cortical and spinal cord mixed glial
cultures (Fig. 1c). Furthermore, FACS analysis of cells double
labelled with GFAP and CD11b demonstrated that there were
no significant differences between the proportion of astroglia
(~ 80%) and microglia (~ 10–20%) in cortical and spinal cord
cultures (Fig. 1d, e). Therefore, in the experiments that follow,
any differences in the stress responses of glial cultures
established from the spinal cord and cortex were not due to
a difference in the cellular composition of the cultures.
Spinal cord–derived glial cultures produce more NO
and express higher levels of iNOS in response
to inflammatory stimuli than cortical glia
NOwas as used as marker of the glial inflammatory response,
based on previous studies of glial cells in neurodegenerative
conditions, including Parkinson’s disease and ALS (Drechsel
et al. 2012; Tripathy et al. 2015). We compared the ability of
cortical and spinal cord mixed glial cultures to produce NO in
response to increasing concentrations of pro-inflammatory
stimuli: the endogenous pro-inflammatory cytokine TNF-ɑ
and the bacterial endotoxin LPS. Although baseline NO pro-
duction in cortical and spinal cord-derived glial cells was very
similar, spinal cord glia produced significantly higher levels of
nitrite and nitrate than cortical glia when stimulated with in-
creasing concentrations of LPS or TNF-ɑ (Fig. 2a, b). The
data in Fig. 2a, b demonstrates that the CNS region from
which the glial cultures were derived significantly affected
the concentration of nitrite in response to each inflammatory
mediator, with spinal cord glial cultures generating a 2–4-fold
greater concentration of nitrite compared to cortical glia after
LPS treatment and 5–12-fold greater concentration after
TNF-α treatment.
Next, we sought to determine the source of NO production
in these mixed glial cultures. NO can be produced by several
different enzymes including endothelial nitric oxide synthase
(eNOS), neuronal nitric oxide synthase (nNOS) and iNOS
(Yuste et al. 2015). To determine the source of the NO syn-
thesis, LPS- and TNF-α-treated mixed glial cultures were pre-
treated with 1400W, a compound that has previously been
shown to selectively and irreversibly inhibit iNOS activity in
primary cultures at a range of concentrations (5–400 μM)
(Garvey et al. 1997; Saura et al. 2005). The iNOS-specific
inhibitor, 1400W, completely inhibited NO production in both
cortical- and spinal cord–derived mixed glial cultures
(Fig. 2c, d), confirming that the NO measured in the media
in our cultures was a product of iNOS activity. In line with the
increased NO production, there was a significant, threefold
increase in iNOS expression in LPS-treated spinal cord glia
compared to cortical glia (Fig. 2e, f). TNF-α treatment did not
lead to detectable iNOS expression. The low concentration of
NO detected after TNF-α treatment could be the consequence
of lower iNOS expression, which may be below the detection
limit of the iNOS antibody with the immunoblotting proce-
dure used in this work.
Thus, although under baseline conditions cortical and spi-
nal cord glial cultures produced very similar, low levels of NO
and no detectable iNOS, spinal cord glia more readily in-
creased iNOS expression and produced higher levels of NO
than cortical glia when exposed to the same level of inflam-
matory stimuli. These findings suggest that spinal cord glia
have a lower threshold for the activation of the NFκ-B-
mediated inflammatory pathway and a stronger inflammatory
response than cortical glia.
Expression of SOD1G93A in glia does not result
in elevated NO production or higher iNOS expression
Glial cells are known to play a key role in determining the
extent of motor neuron death in ALS (Boillee et al. 2006;
Yamanaka et al. 2008). In order to assess whether the
increased react ivi ty of spinal cord gl ia to pro-
inflammatory stimuli observed in the previous experi-
ments may contribute to the greater neuronal loss in the
spinal cord of SOD1G93A mice compared to the cortex, we
next investigated the induction of the NFκ-B-mediated
inflammatory pathway in primary mixed glial cultures de-
rived from SOD1G93A mice. Although spinal cord mixed
glial cultures demonstrated significantly higher concentra-
tions of NO in both WT and SOD1G93A cultures compared
with corresponding cortical cultures, there were no
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differences in either NO production or iNOS expression
between WT and SOD1G93A cultures from either region
(Fig. 3). These findings suggest that the expression of
SOD1G93A in cortical and spinal cord glial in itself does
not exacerbate NO production nor induce detectable iNOS
expression in response to inflammatory stimuli.
Fig. 1 Characterisation of glial cultures reveals that cultures from the
cortex and spinal cord have a similar cellular composition. a Mixed
glial cultures at 12 days in vitro stained for glial markers GFAP (red,
astrocytes) and iba-1 (green, microglia). b Quantification of GFAP and
iba-1 expressing cells in cortical and spinal cord mixed glial cultures. c
ELISA assay for GFAP expression in cortical and spinal mixed glial cells.
d Characterisation of cortical and spinal cord mixed glial cultures per-
formed by FACS analysis of GFAP-positive (astrocytes, Y axis) and
CD11b (microglia, X axis)-positive cells. eQuantification for FACS anal-
ysis of cortical and spinal cord mixed glial cultures. Error bars = S.E.M.
Scale bar, 20 μm
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Cortical and spinal cord glia elicit a similar heat shock
response
Glial cells provide protection to neurons in diverse ways, in-
cluding through elevation of the HSR under conditions of
stress. Therefore, we next studied the ability of glia to induce
the HSR after exposure to inflammatory stimuli and heat
shock, and examined whether there were differences in the
HSR of spinal and cortical glia.
As shown in Fig. 4 a and b, exposure to inflammatory
stimuli (LPS and TNF-ɑ) did not cause a significant HSR in
either spinal or cortical wild-type glial cells. However, follow-
ing heat shock, there was a significant HSR in both cortical-
and spinal cord–derived glial cultures, with a clear increase in
expression in Hsp70, which was upregulated to a similar ex-
tent in spinal cord and cortical cultures (Fig. 4c, d).
Expression of ALS-causing SOD1G93A impairs Hsp70
upregulation in glia following heat stress
We next compared the level of heat shock–induced upregula-
tion of Hsp70 between WT glia and glia expressing mutant
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Fig. 2 Elevated NO production and iNOS expression in spinal cord–
derived glial cultures compared to cortical glia in response to inflamma-
tory stimuli. Nitrite/nitrate production in response to increasing concen-
trations of LPS (a) or TNF-ɑ (b), and the specific iNOS inhibitor 1400W
(c, d) was measured using a Griess assay. e Immunoblot for iNOS ex-
pression in cortical and spinal cord mixed glial cultures exposed to LPS or
TNF-ɑ. f Quantification of immunoblots for iNOS in cortical and spinal
cord mixed glial cultures exposed to LPS or TNF-ɑ. Error bars = S.E.M.
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SOD1G93A. As can be seen in Fig. 4c, d, the HSR of glia
expressing SOD1G93A was reduced compared to WT glia, so
that following exposure to heat stress, the increase in Hsp70
expression was greater in WT than in SOD1G93A glial cul-
tures. This suggests that the expression of ALS-causing mu-
tant SOD1G93A induces a deficit in the cytoprotective HSR in
SOD1G93A glia. Interestingly, this deficit in stress-induced
Hsp70 induction was present in both cortical and spinal cord
glial cultures expressing the SOD1G93A mutation.
Taken together, our results show that spinal cord glia dis-
play a greater inflammatory response following exposure to
inflammatory stimuli than cortical glia, and this differential
stress response is not altered by the expression of mutant
SOD1G93A. In contrast, the HSR of glia is not influenced by
the CNS region of origin, but is diminished in SOD1G93A
expressing glia from both the cortex and the spinal cord.
Heat stress reduces the activation of NF-κB signalling
and iNOS expression in spinal cord glia
Previous studies have shown that there is crosstalk between
the HSR and the NF-κB-mediated inflammatory pathway
(Chen et al. 2006; Ran et al. 2004). Heat stress reduces
iNOS activity and mRNA levels induced by LPS treatment
in cortical astroglial cultures (Feinstein et al. 1996). Therefore,
we next investigated whether there is a relationship between
the protective HSR and the pro-inflammatory NF-κB-
mediated inflammatory pathway in the spinal cord and cortical
glia. We combined LPS and heat shock treatments to deter-
mine whether induction of the HSR regulates the activation of
the NF-κB-mediated inflammatory pathway in cortical- and
spinal cord–derived mixed glial cultures.
The results summarised in Fig. 5 show that heat shock
limited the increase of iNOS expression in spinal cord glia
observed following treatment with LPS (Fig. 5a, b).
Phosphorylation of the NF-κB complex, the upstream effector
of iNOS, is required for its transcriptional activity (Hayden
and Ghosh 2008). In line with decreased iNOS expression,
heat stress caused an attenuation of LPS-induced phosphory-
lation of the NF-κB complex in spinal cord glia, but not cor-
tical glia (Fig. 5a, c). Increased Hsp70 expression following
heat stress was unaffected by the addition of LPS in spinal
cord glia (Fig. 5d, e).
Furthermore, although treatment of spinal cord glia with in-
flammatory stimuli induced a clear increase in iNOS levels, this
effect was reduced by heat stress (Fig. 5). The inhibitory effect
of heat stress on the induction of iNOS may be mediated by a
heat shock–induced increase in Hsp70, which is known to limit
activation of NF-κB (Chen et al. 2006) (Fig. 5c). Compared to
cells treated with LPS alone, spinal cord glia exposed to both
heat stress and LPS displayed a reduced activation of NF-κB, as
determined by the levels of phosphorylated NF-κB.
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Fig. 3 SOD1G93A andWT glia produce similar levels of NO and iNOS in
response to inflammatory stimuli. a Nitrite/nitrate production of WT and
SOD1G93A glia following treatment with 80 μg/ml LPS and/or 1400W
(b). c Immunoblot for iNOS expression inWTand SOD1G93Amixed glial
cultures. d Quantification of immunoblots for iNOS expression in WT
and SOD1G93A mixed glial cultures. Error bars = S.E.M.
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Discussion
The abundance of glial cells and the support they provide to
different neuronal populations varies across different regions
of the CNS. In this study, we explored whether regional dif-
ferences between cortical- and spinal cord–derived glia exist
in terms of their response to inflammatory stimuli and activa-
tion of the HSR. Activation of the NF-κB-mediated inflam-
matory pathway in glial cells is thought to contribute to an
accelerated disease progression in neurodegenerative diseases
such as ALS and, therefore, differences in this pathway might
hold important clues for the selective vulnerability of different
neuronal cell populations in disease. The results of this study
show that, compared to cortical glia, glia from the spinal cord
were more prone to inflammatory stimuli and produced ele-
vated levels of iNOS, which resulted in increased NO release.
Interestingly, expression of cytoprotectiveHsp70was not aug-
mented in spinal cord cultures compared to cortical glia in
response to heat stress or inflammatory stimuli, suggesting
that the magnitude of the HSR is similar in cortical and spinal
cord glia.
We also examined glial cultures obtained from mice over-
expressing the ALS causing SOD1G93Amutation to reveal any
disease-relevant alterations in inflammatory responses and the
HSR in different glial populations. Interestingly, we found that
although the inflammatory response in SOD1G93A expressing
glia was the same as in wild-type glia from corresponding
regions, SOD1G93A expressing glia had a significant impair-
ment in the ability to upregulate Hsp70 in response to stress.
Activation of NF-κB drives iNOS expression and subse-
quent NO production, which has been shown to play a role in
the pathomechanisms of ALS (Yuste et al. 2015). Knockout or
pharmacological inhibition of iNOS using 1400W extends the
lifespan of SOD1G93A mice (Martin et al. 2007; Chen et al.
2010). Furthermore, blocking NO production with 1400W
has also been shown to be beneficial in several other patholog-
ical conditions, reducing aggregate formation in a model of
ischaemia (Chen et al. 2012) and traumatic brain
injury (Jafarian-Tehrani et al. 2005), and reducing pain hyper-
sensitivity in amodel of neuropathic pain (Staunton et al. 2018).
While activation of NF-κB, the upstream effector of iNOS,
is well established in animal models and human ALS (Casciati
et al. 2002; Migheli et al. 1997; Sako et al. 2012; Xu et al.
2018), the involvement of the various cellular components of
NF-κB activation and its role in disease is ambiguous. NF-κB
activation has been shown to be detrimental to motor neuron
survival (Ikiz et al. 2015), although NF-κB deficiency in mo-
tor neurons had also been reported to cause motor neuron
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Fig. 4 Hsp70 upregulation is impaired following heat stress in
SOD1G93A cortical and spinal cord glial cultures. a Immunoblot for
Hsp70 in cortical and spinal cord glia treated with 80 μg/ml LPS or
100 ng/ml TNF-ɑ. b Quantification of immunoblot for Hsp70 in cortical
and spinal cord glia treated with 80 μg/ml LPS or 100 ng/ml TNF-ɑ. c
Immunoblot for Hsp70 in WT and SOD1G93A cortical and spinal cord
mixed glial cultures treated with 80 μg/ml LPS or heat shock of 42 °C for
30min. dQuantification of immunoblot for Hsp70 inWTand SOD1G93A
cortical and spinal cord mixed glial cultures treated with 80 μg/ml LPS or
heat shock of 42 °C for 30 min. Error bars = S.E.M.
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death in ALS (Sulejczak et al. 2015). With respect to the role
of NF-κB in glial cells, some reports suggest that microglia are
the key cellular components regulating neuroinflammation
through NF-κB activation (Frakes et al. 2014), whereas
astroglial NF-κB activation has no role in disease (Crosio
et al. 2011). A more subtle, regulatory role has been proposed
for astroglial NF-κB activation, in which astroglial NF-κB
regulates inflammatory processes differently at different
stages of the inflammatory pathway (Ouali Alami et al.
2018). Previous reports have also suggested a dual role for
astroglial NF-κB in ALS, whereby complete abolition of this
important master regulator is as detrimental as its over-
activation (Lee et al. 2006).
An important aspect of glial function is to respond to envi-
ronmental and physiological stressors in order to protect the
viability of neurons. In post-mortem tissues of ALS patients,
there have been reports of reduced Hsp70 expression, while
there is also evidence for Hsp70 accumulating in intracellular
aggregates in the spinal cord (Bruening et al. 1999; Watanabe
et al. 2001), which in turn creates a deficit of cytosolic Hsps
(Koyama et al. 2006; Zetterstrom et al. 2011; Okado-
Matsumoto and Fridovich 2002). Depletion of cytosolic
Hsps is a phenomenon not only exclusively present in the
diseased CNS, but has also been described in aged tissues,
including in astroglia (Boisvert et al. 2018). It has been
proposed that age-dependent failure of the HSR contributes
to the development of neurodegenerative conditions
and therefore HSR dysfunction may be part of the primary
pathology of neurodegenerative diseases including ALS
(Calderwood and Murshid 2017). Thus, increasing Hsp levels
in neurons and glial cells has been investigated as an attractive
therapeutic target for protein misfolding diseases such as ALS
(Kalmar et al. 2014; Kieran et al. 2004; Waza et al. 2005).
The HSR and its central effector, Hsp70, also play an
important role in other cellular processes implicated in
ALS, including stress granule formation, autophagy and
proteasomal degradation, as well as inflammatory signal-
ling (Kalmar and Greensmith 2017; Luders et al. 2000;
Fig. 5 Heat stress reduces levels of LPS-induced iNOS and pNF-κB in
spinal cord mixed glial cultures. a Immunoblot for iNOS and pNF-κB
expression following treatment with heat shock at 42 °C for 30min and/or
80 μg/ml LPS. Quantification of immunoblots for iNOS (b) and pNF-κB
(c) following treatment with heat shock at 42 °C for 30 min and/or
80 μg/ml LPS. d Immunoblot for Hsp70 expression following treatment
with heat shock at 42 °C for 30 min and/or 80 μg/ml LPS. e
Quantification of immunoblots for Hsp70 following treatment with heat
shock at 42 °C for 30 min and/or 80 μg/ml LPS. Error bars = S.E.M.
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Walters and Parker 2015; Kon and Cuervo 2010; Kabashi
et al. 2004; Yost and Lindquist 1991; Osaka et al. 2016;
Ganassi et al. 2016).
It is possible that intrinsic differences in these stress re-
sponses of glia from different regions of the CNS could con-
tribute to the vulnerability of specific neuronal groups to spe-
cific stressors, leading for example to the selective death of
motor neurons in ALS, or dopaminergic neurons in
Parkinson’s disease. In this study, Hsp70 expression was used
as a marker for activation of the HSR as this major Hsp is the
most responsive to environmental stressors (Sharp et al. 2001;
Nollen and Morimoto 2002). However, we did not observe
any intrinsic regional differences between the stress-induced
expression of Hsp70 in spinal cord and cortical glia.
Interestingly, there was an impairment of Hsp70 induction in
response to heat stress in both cortical and spinal cord glia
expressing SOD1G93A. Thus, although there were no region-
specific differences in Hsp70 expression between cortical and
spinal cord glia, SOD1G93A glia from both regions displayed
an impaired Hsp70 induction in response to stress compared
to WT glia.
We also investigated the possibility that the NF-κB-
mediated inflammatory pathway and the HSR may interact
with each other in a region-specific manner. The protective
effects of heat shock in neuroinflammatory and neuronal stress
conditions are well characterised (Murphy et al. 2002; Zheng
et al. 2008; Gifondorwa et al. 2007). This protective effect is at
least partly attributed to the effects of elevated Hsp70 levels
inhibiting iNOS activation (Feinstein et al. 1996). Indeed, it
has been shown that pharmaceutical upregulation of Hsp70
can lead to increased resistance to pro-inflammatory stimuli
in glial cells (Kacimi and Yenari 2015). In view of the negative
regulation of NF-κB by Hsp70 to stimuli in spinal cord glia of
WT and SOD1G93A cultures, we hypothesise that impaired
Hsp70 induction could contribute to an exacerbated inflam-
matory response in ALS. Our results show that in spinal cord–
derived glial cells exposed to a combination of heat stress and
inflammatory stimuli, expression of iNOS and activation of
NF-κBwas indeed lower than in glia exposed to inflammatory
stimuli alone. Interestingly, in our experiments, we did not
observe a cumulative effect of these two stressors on the ex-
pression of Hsp70 and thus, it appears that the heat shock–
induced activation of the HSR is sufficient to limit the inflam-
matory pathway. Therefore, elevated levels of Hsp70 can limit
the activation of iNOS expression and potentially achieve
therapeutic benefits.
Conclusions
The results of this study show that spinal cord–derived glia are
intrinsically more prone to activation of the NF-κB-mediated
inflammatory pathway and iNOS induction than glia derived
from the cortex, which may contribute to the selective vulner-
ability of spinal cord motor neurons in SOD1G93A ALS mice.
Expression of SOD1G93A limited the induction of the HSR,
resulting in the removal of the negative regulation of NF-κB
activation by Hsp70. Our results suggest that since anti-
inflammatory approaches alone have not proved successful
in ALS, a more effective therapeutic strategy to combat motor
neuron death in ALS should involve intervention at multiple
levels, for example, strengthening the intrinsic stress re-
sponses while also limiting inflammation.
Experimental procedures
Breeding andmaintenance of SOD1G93A andwild-type
mice
All experiments were performed in accordance with the
Animals (Scientific Procedures) Act 1986 and following ap-
proval from the Institute of Neurology’s Animal Welfare and
Ethical Review Board. Mice were housed in individually ven-
tilated cages on a 12-h light/dark cycle with food and water
made ava i lab le ad l ib i tum. SOD1G93A (B6SJL-
Tg(SOD1*G93A) 1Gur/J), overexpressing human mutant
SOD1G93A (glycine to alanine substitution at position 93),
were originally obtained from Jackson Laboratories (USA)
along with wild-type (WT) littermates. Mice were maintained
by breeding heterozygous male carriers with female (C57BL/
6 × SJL) F1 hybrids. WT mice used in this study were obtain-
ed from the same colony and thus had the same genetic back-
ground as the SOD1G93A mouse colony. Tail biopsies were
genotyped for expression of mutant SOD1G93A by PCR am-
plification of genomic DNA, analysed by electrophoresis
using a 2% agarose (Sigma-Aldrich) gel stained with
GelRed (Sigma-Aldrich) and visualised using a ChemiDoc
imager (Bio-Rad).
Primary mixed cortical and spinal cord glial cultures
Primary mixed glial cultures were obtained from SOD1G93A
and WT mice at postnatal day 2–3. Mice were humanely
killed by decapitation and spinal cords and cortices were dis-
sected, meninges removed and cut into small 1 mm× 1 mm
pieces. Tissue was then digested in 0.025% trypsin, 0.017%
(w/v) DNase I (Sigma-Aldrich), 0.3% (w/v) Bovine Serum
Albumin (BSA) and 1% penicillin/streptomycin in Hanks
Balanced Salt Solution (HBSS) (Thermo Fisher) for 10 min
at 37 °C. Foetal bovine serum (FBS) (Thermo Fisher) was
used to inhibit the proteolytic reaction. Tissue was triturated
10–15 times and then centrifuged at 1000×g for 5 min. The
resulting cell pellet was resuspended in feeding media con-
taining 15% FBS and 1% penicillin/streptomycin in DMEM
supplemented with 2 mM Glutamax (Thermo Fisher) and
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filtered through a 100-μm nylon strainer before being seeded
on plates coated with 10 μg/ml poly-D-lysine. Cells were
maintained under standard culture conditions (37 °C and 5%
CO2) and media were replenished every 3 days.
Treatment of primary mixed glial cultures
After being maintained for 12 days in vitro, when primary
cortical and spinal cord mixed glial cultures are confluent
and at a quiescent state, without substantial presence of
microglial proliferation, cells were treated with either of the
inflammatory inducers: tumour necrosis factor-alpha (TNF-ɑ)
(10–200 ng/ml) or lipopolysaccharide (LPS) (2–100 μg/ml)
for 24 h, or heat shocked at 42 °C for 30 min and allowed to
recover at 37 °C for 24 h. In instances where cultures were
treated with both LPS and heat shocked, cultures were treated
with LPS, immediately heat shocked at 42 °C for 30 min and
then incubated at 37 °C for 24 h. In some instances, cells were
also pre-treated for 2 h with 1400W, a specific iNOS inhibitor,
used at 25 μM. Cells were subsequently processed for immu-
noblotting, immunostaining or flow cytometric analysis at var-
ious timepoints but in most cases, if not mentioned, 24 h later.
Immunofluorescence staining
Primary mixed glial cultures were fixed in 4% paraformalde-
hyde (PFA) in phosphate buffered saline (PBS) for 10 min and
then washed with PBS. Cells were then blocked for 1 h at
room temperature (RT) in blocking solution consisting of
5% normal donkey serum in PBS containing 0.1% Triton X-
100 (PBST). Primary antibodies rabbit anti-GFAP 1:10,000
(abcam ab7260) and rabbit anti-Iba-1 1:100 (Wako
LKR1186) were then added in blocking solution overnight
at 4 °C. The following day, cells were washed with PBS and
then incubated in secondary antibodies (anti-rabbit or anti-
mouse Alexa Fluor® 488 or Alexa Fluor® 596 raised in don-
key, by Thermo Fisher, used at 1:1000) in blocking solution
for 2 h at RT. After another set of PBS washes, a DAPI stain
was applied (Sigma-Aldrich, 1:2000) to stain nuclei and then
cells were mounted with Mowiol mounting media and stored
at 4 °C. Imaging was performed using a Leica inverted
epifluorescence light microscope and Leica Application
Suite software. The proportion of cells that were GFAP+ve or
Iba1+ve were determined using MetaMorph Image Analysis
Software (Molecular Devices, CA, USA) by using the number
of DAPI-labelled nuclei as the total number of cells in the
culture.
Immunoblotting
Primary mixed glial cultures were washed with PBS and then
lysed on ice with RIPA buffer (50 mM Tris pH 7.5, 150 mM
NaCl, 1% NP40, 0.5% sodium deoxycholate, 1 mM EGTA,
1 mM EDTA and protease and phosphatase inhibitors (Halt™
Protease and phosphatase Inhibitor Cocktail, Thermo Fisher)).
Protein content of samples from primary mixed glial cultures
was estimated by protein assay (Bio-Rad DC protein assay)
according to the manufacturer’s instructions with absorbance
at 750 nm measured using a FLUOstar Omega microplate
reader (BMG LabTech). Samples were subsequently diluted
to equal concentrations in RIPA buffer and then added 4:1 in
sample buffer (Laemmli buffer supplemented with 10% β-
mercaptoethanol) and heated at 95 °C for 10 min to denature
proteins. Protein samples were loaded onto precast 4–12%
NuPage Bis-Tris gels (Thermo Fisher) and run in NuPage
MES SDS running buffer (Thermo Fisher) at 160 V for 1 h.
Protein was then transferred onto nitrocellulose membranes
(Amersham Biosciences) at 100 V for 1 h in transfer buffer
(National Diagnostics) containing 20% methanol. A Ponceau
S stain (Sigma-Aldrich) was used to confirm efficient protein
transfer before membranes were blocked in 5% BSA (VWR)
in Tris buffered saline with 0.1% Tween 20 (TBST) for 1 h.
Membranes were then probed with primary antibodies mouse
anti-Hsp70 1:1000 (SantaCruzW27: Sc-24), rabbit anti-iNOS
1:1000 (abcam ab178945), rabbit anti-phospho-NF-κB (p65)
(Ser536) 1:1000 (Cell Signalling 93H1: #3033), mouse anti-
GAPDH 1:1000 (Millipore AB2302), mouse anti-ɑ-tubulin
1:1000 (Thermo Fisher 236-10501) and mouse anti-β-actin
1:40,000 (abcam ab8226) diluted in blocking solution and left
on a shaker overnight at 4 °C. The next day membranes were
washed in TBST and then incubated with secondary antibody
(anti-mouse or anti-rabbit Ig conjugated to horseradish perox-
idase (Dako), used at 1:5000) for 2 h at RT. After another set
of TBST washes, proteins were visualised using Luminata
Crescendo chemiluminescence reagent (Millipore). Images
were taken using a ChemiDoc imager (Bio-Rad) and bands
were quantified using ImageLab software (Bio-Rad). Relative
changes in protein expression were measured and normalised
to housekeeping proteins β-actin, ɑ-tubulin or GAPDH.
Flow cytometry
Primary mixed glial cultures were suspended using 0.025%
trypsin and washed once with PBS. Cells were fixed in 4% (w/
v) paraformaldehyde for 15 min in suspension, washed twice
in PBS and then permeabilised and blocked in 5% (v/v) nor-
mal goat or donkey serum (or BSA) PBST for 1 h at RT. Cells
were then incubated with primary antibodies mouse anti-
GFAP conjugated to Cy3 1:1000 (Sigma-Aldrich), and mouse
anti-CD11b antibody conjugated to Cy7 1:1000 (Tonbo
Biosciences) in 3%BSA in PBS for 2 h at RTand thenwashed
three times in PBS. The entire immunolabelling process was
conducted with gentle rocking at each step to ensure appro-
priate mixing of cells with fixing, permeabilising, blocking
and antibody solutions. Cells were then centrifuged at
400×g for 5 min and resuspended in PBS before being
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analysed using a FACS Aria II equipped with a 488 nm,
561 nm and 633 nm lasers. A minimum of 20,000 events
per sample was collected at a high flow rate. Forward scat-
ter was collected using a linear scale and side scatter in log
scale, and fluorescent emissions were collected as area (log
scale) for each channel. For Cy3 fluorescence, data were
collected with the 561 nm laser and 582/15 bandpass filter.
For Cy7 fluorescence, data were collected with the 633 nm
laser and the 670 longpass filter.
Nitric oxide production measurements
Release of nitric oxide from primary mixed glial cultures fol-
lowing exposure to inducers of inflammatory signalling was
indirectly measured using a Griess assay. Media from cultures
were collected 24 h after treatment and nitrates in the culture
were converted to nitrite by incubatingmedia with nitrate reduc-
tase (0.028U/ml) andβ-NADPH (100μM) for 15min at 37 °C.
Media were then mixed in a 1:1 ratio with modified Griess
reagent (Sigma-Aldrich). Sodium nitrite standards (NaNO2)
were prepared in feeding media and absorbance measured using
a spectrophotometer at 540 nm. Total protein levels were then
measured (Bio-Rad DC protein assay) using a spectrophotom-
eter at 750 nm and nitrite levels were normalised accordingly.
ELISA
GFAP expression in cortical and spinal cord mixed glial
cultures were compared quantitatively using a GFAP
ELISA (Petzold et al. 2004). Briefly, a 96-well flat bottom
plate (Maxisorb NUNC, VWR) was coated overnight at
4 °C with the capture antibody, mouse anti-GFAP
(1:1000), in 0.05 M carbonate buffer, pH 9.5. The plate
was washed in barbitone buffer (14.22 μM sodium barbi-
tone, 2.28 μMbarbital, 0.24 μMEDTA) supplemented with
0.2% BSA and 0.05% Tween 20. After washing, 50 μL of
sample diluent (barbitone buffer supplemented with 6 mM
EDTA, and 0.2% BSA) and 50 μL of GFAP standards or
whole cell lysates from mixed glial cultures were then
added in quadruplicate to the plate. The plate was incubated
for 1 h at RT. After washing with barbitone buffer, the
secondary antibody (bovine anti-GFAP antibody 1:1000)
was diluted in barbitone buffer, added to each well and
incubated for 1 h at RT. After washing, the tertiary antibody
(HRP-conjugated swine anti-rabbit IgG 1:1000) was
diluted in barbitone buffer and added to each well. The plate
was then incubated with supersensitive 3, 3′, 5, 5′
tetramethylbenzidine liquid substrate (Sigma-Aldrich) for
30 min at RT in the dark. The reaction was stopped by
adding 1 M HCl and the absorbance was read spectropho-
tometrically at 450 nm, with 750 nm as the reference wave-
length on a Wallac Victor 2 plate reader. Concentration of
GFAP content in the samples was then calculated by
comparing absorbance values to absorbance values mea-
sured from a standard curve containing samples of known
concentrations of GFAP.
Statistical analysis
Results are presented as the mean ± SEM for at least three
biological repeats (three litters of newborn mice). Differences
between the means were assessed by ANOVA with post hoc
comparisons tests or Mann-Whitney U test when appropriate
using GraphPad Prism Version 7.0 software. Statistical signif-
icance was set at p = 0.05. Significance is indicated in the
figures where appropriate and depicted as: *p < 0.05
**p < 0.01 ***p < 0.001. Scale bar 20 μm.
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